Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

Oramed Pharmaceuticals  / Equity Bottom-Up

<ul><li>Having completed an analysis of data from its terminated ORA-D-013-1 Phase 3 trial, Oramed is optimistic about prospects for ORMD-0801, particularly for certain subpopulations of patients with specific parameters that match those of study participants who responded well to oral insulin.</li><li>ORMP has initiated discussions with the FDA and plans to launch a Phase 3 oral insulin trial in the U.S. under a differentiated protocol aligned with the positive data.</li><li>Separately, a recent licensing agreement with Genomma Lab could provide attractive royalty revenue, if Genomma can commercialize an OTC hemorrhoids treatment & other products for which ORMP had acquired the rights.</li></ul>

Having completed an analysis of data from its terminated ORA-D-013-1 Phase 3 trial, Oramed is optimistic about prospects for ORMD-0801, particularly for certain subpopulations of patients with specific parameters that match those of study participants who responded well to oral insulin.ORMP has initiated discussions with the FDA and plans to launch a Phase 3 oral insulin trial in the U.S. under a differentiated protocol aligned with the positive data.Separately, a recent licensing agreement with Genomma Lab could provide attractive royalty revenue, if Genomma can commercialize an OTC hemorrhoids treatment & other products for which ORMP had acquired the rights.

ORMP: Moving Oral Delivery Platform Forward, + Potential to Generate Royalties

Israel

RedHill Biopharma is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. RedHill's pipeline includes several drug candidates in advanced clinical development stages, including three Phase III-stage programs. The company promotes GI products in the U.S.

BioLineRx Ltd. is a clinical-stage biopharmaceutical company, which includes indentifying, in-licensing, and developing therapeutic candidates. Its in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, and develops them through pre-clinical and clinical stages, and then partners with pharmaceutical companies clinical development and commercialization. The company was founded in April 2003 and is headquartered in Modi'in, Israel.

CollPlant Holdings Ltd. produces and distributes pharmaceutical products. The Company offers wound care, orthopedics, and tissue repair medicines. CollPlant Holdings conducts its business in the United States.

BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.

Clal Biotechnology Industries Ltd., invests in companies within the biological sector.

ReWalk Robotics Ltd. produces a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk. ReWalk is available throughout the United States.

Allium Medical Solutions Ltd develops and produces medical equipment. The Company manufactures and markets minimally invasive products. Allium Medical Solutions serves customers worldwide.

Sisram Medical Ltd manufactures medical equipment. The Company produces epilators, vascular therapy devices, pigmented variable treatment equipment, minimally invasive beauty equipment, and other equipment. Sisram Medical markets its products to medical beauty institutions worldwide.

Teva Pharmaceutical Industries Limited operates as a pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals, as well as active pharmaceutical ingredients. Teva Pharmaceutical Industries serves customers worldwide.

Samsung Pharmaceutical Co., Ltd. manufactures medicines to treat a variety of diseases.  The Company's products include medicines for inflammatory, nutrition, and digestive system.

Jeil Pharma Holdings Inc. operates as a pharmaceutical manufacturing company. The Company manufactures analgesic anti-inflammatories, broad-spectrum oral antimicrobial agents, analgesic anti-cold poultice poultices, hyperlipidemia agents, intravenous antibiotics, and other products. Jeil Pharma Holdings markets its products throughout Korea.

Daehan New Pharm Co., Ltd. develops, manufactures, and markets pharmaceutical drugs, such as vaccines, diagnostic kits, and antibiotics.  The Company also produces various veterinary drugs and baby cares.  Daehan New Pharm exports its products to Japan, Malaysia, Vietnam, and Brazil.

PT Merck Tbk manufactures pharmaceutical products. The Company also distributes pharmaceutical raw materials, chemicals reagents, and medical instruments.

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. researches, manufactures, and markets traditional Chinese medicines, western medicines, and biomedicines.  The Company also manufactures printed circuit boards and paper products.

Hangzhou Tian Mu Shan Pharm. Enterp. Co (600671 CH)

Chunghwa Chemical Synthesis & Biotech Co Ltd is a biomedical company. The Company contract manufactures a wide range of pharmaceutical products, including pain management, antifungal, immunosuppressant, as well as provides synthesis and biotechnology technologies.

Chunghwa Chemical Synthesis & Biotech (1762 TT)

Ind-Swift Laboratories Ltd. manufactures bulk drugs and intermediates.  The Company's product portfolio includes anti-infective, anti-allergy, analgesic and cardiovascular medicines.

Johnson Chemical Pharmaceutical Works Corp. develops medical and biotechnology products.

Jagsonpal Pharmaceuticals  develops and  manufactures bulk drugs and pharmaceutical formulations.

RaQualia Pharma, Inc. is a pharmaceutical company. The Company develops compounds for patient studies and sells drugs to pharmaceutical manufacturers. RaQualia also provides research on remedies in gastrointestinal, liver diseases, and pain in general areas.

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oramed Pharmaceuticals (ORMP US)

ORMP: Moving Oral Delivery Platform Forward, + Potential to Generate Royalties

Having completed an analysis of data from its terminated ORA-D-013-1 Phase 3 trial, Oramed is optimistic about prospects for ORMD-0801,...

Zacks Small Cap Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)